- Release Date: 13/09/22 09:12
- Summary: Rett Syndrome NDA accepted for Priority Review by FDA
- Price Sensitive: Yes
- Download Document 231.46KB
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.76 |
Change
0.590(3.89%) |
Mkt cap ! $1.959B | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.92 | $15.24 | $5.976M | 382.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 100 | $15.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.76 | 103 | 3 |
View Market Depth
| Last trade - 14.40pm 22/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |